Dr. Jorg Taubel and Dr. Ulrike Lorch will be attending the DDI Marbach Workshop, now in its 14th year. The Marbach Workshop continues to serve as a forum for in-depth discussions on crucial topics surrounding drug-drug interactions (DDIs).

As part of the Marbach Castle Drug-Drug Interaction Workshop Series, this event brings together stakeholders from various backgrounds, including the pharmaceutical industry, regulatory authorities, academia, and healthcare delivery.

The workshop series, a non-profit initiative, aims to facilitate the exchange of research-based knowledge on DDIs, encompassing not only drug-drug interactions but also food-drug and herb-drug interactions. By fostering communication and collaboration across disciplines and organisational boundaries, the workshop series seeks to advance scientific understanding and promote safer use of pharmaceutical products, particularly in geriatric and medically complex patient populations.

This year's workshop will be held at the Marbach Castle Conference Centre, nestled amidst the picturesque surroundings of the Western shore of Lake Constance, near the historic town of Stein am Rhein. It's an unparalleled opportunity to engage with leading experts, exchange insights, and contribute to the advancement of DDI research and clinical practice.

To find out more: https://www.ddi-workshop-marbach.org/ 

Latest news

Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1

March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event